Post-Stroke Cognitive Impairments and the Potential for Treatment with Cellex

被引：0

作者：

Kulesh A.A. ^{[1
]}

Shestakov V.V. ^{[1
]}

机构：

[1] Vagner Perm State Medical University, Perm

来源：

Neuroscience and Behavioral Physiology | 2017年 / 47卷 / 8期

关键词：

Cellex; cognitive impairments; memory; neuropsychology; stroke;

D O I：

10.1007/s11055-017-0490-3

中图分类号：

学科分类号：

摘要：

Objective. To assess the neuropsychological characteristics of post-stroke cognitive impairments (PSCI) in the acute period of ischemic stroke (IS) and to evaluate the efficacy of Cellex. Materials and methods. Complex neuropsychological testing was performed in 288 patients in the acute period of IS. Cellex was used in addition to basal treatment in 30 patients at a dose of 0.1 mg (1 ml) s.c. for 10 days, with treatment being initiated in the hyperacute period. Results and discussion. Multifunctional PSCI was detected in 87% of the patients in the acute period of IS. Most patients showed impairments to attention, regulatory functions, speech, and memory. More than a third of patients showed multifunctional non-amnestic cognitive impairments. Monofunctional nonamnestic PSCI was encountered in 5.5% of cases. Isolated memory deficit was found in 2% of patients. Most elderly patients displayed PSCI, mostly the mixed variant. Isolated decreases in the rate or regulation of cognitive activity dominated among young and middle-aged patients, with one in four patients showing mixed cognitive impairments. A tendency to greater age was seen in patients with mixed-type PSCI. Analysis of the efficacy of Cellex in the acute period of IS showed that use was linked with improvements in cognitive status and the state of neurodynamic, regulatory, and visuospatial functions. The neurotrophic agent Cellex was effective in correcting PSCI in the acute period of IS. © 2017, Springer Science+Business Media, LLC.

引用

页码：908 / 912

页数：4

共 14 条

[1] Gutierrez Perez C., Savborg M., Pahlman U., Et al., High frequency of cognitive dysfunction before stroke among older people, Int. J. Geriatr. Psychiatry, 26, pp. 622-629, (2011)
[2] Looi J.C.L., Sachdev P., Differentiation of vascular dementia from AD on neuropsychological tests, Neurology, 53, pp. 670-678, (1999)
[3] Sachdev P.S., Chen X., Brodaty H., Et al., The determinants and longitudinal course of post-stroke mild cognitive impairment, J. Int. Neuropsychol. Soc., 15, pp. 915-923, (2009)
[4] Gorelick P.B., Scuteri A., Black S.E., Et al., Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 42, 9, pp. 2672-2713, (2011)
[5] Petersen R.C., Mild cognitive impairment as a diagnostic entity, J. Int. Med., 256, 3, pp. 183-194, (2004)
[6] Moscow (2010)
[7] Cho S.J., Yu K.H., Oh M.S., Et al., Post-stroke memory impairment among patients with vascular mild cognitive impairment, BMC Neurol., 14, (2014)
[8] Snaphaan L., de Leeuw F.-E., Post-stroke memory function in nondemented patients: a systematic review on frequency and neuroimaging correlates, Stroke, 38, pp. 198-203, (2007)
[9] Kulesh A.A., Shestakov V.V., Heterogeneity in cognitive impairments in the acute period of first ischemic hemisphere stroke,, Zh. Nevrol. Psikhiat. (Stroke), 8, No. 8, Iss., 2, pp. 31-34, (2012)
[10] Kulesh A.A., Lapaeva T.V., Shestakov V.V., Chronobiological characteristics of stroke and post-stroke cognitive impairments, Zh. Nevrol. Psikhiat., 114, 11, pp. 31-34, (2014)

← 1 2 →